img

Global Afinitor Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Afinitor Drug Market Research Report 2024

Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).
According to Mr Accuracy reports new survey, global Afinitor Drug market is projected to reach US$ 1093.6 million in 2029, increasing from US$ 814 million in 2022, with the CAGR of 4.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Afinitor Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Afinitor Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis
Breckenridge
Segment by Type
2.5mg
5mg
7mg
10mg

Segment by Application


Hospital
Drugs Store
Other

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Afinitor Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Afinitor Drug Market Overview
1.1 Product Overview and Scope of Afinitor Drug
1.2 Afinitor Drug Segment by Type
1.2.1 Global Afinitor Drug Market Value Comparison by Type (2024-2034)
1.2.2 2.5mg
1.2.3 5mg
1.2.4 7mg
1.2.5 10mg
1.3 Afinitor Drug Segment by Application
1.3.1 Global Afinitor Drug Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Afinitor Drug Market Size Estimates and Forecasts
1.4.1 Global Afinitor Drug Revenue 2018-2029
1.4.2 Global Afinitor Drug Sales 2018-2029
1.4.3 Global Afinitor Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Afinitor Drug Market Competition by Manufacturers
2.1 Global Afinitor Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Afinitor Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Afinitor Drug Average Price by Manufacturers (2018-2024)
2.4 Global Afinitor Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Afinitor Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Afinitor Drug, Product Type & Application
2.7 Afinitor Drug Market Competitive Situation and Trends
2.7.1 Afinitor Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Afinitor Drug Players Market Share by Revenue
2.7.3 Global Afinitor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Afinitor Drug Retrospective Market Scenario by Region
3.1 Global Afinitor Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Afinitor Drug Global Afinitor Drug Sales by Region: 2018-2029
3.2.1 Global Afinitor Drug Sales by Region: 2018-2024
3.2.2 Global Afinitor Drug Sales by Region: 2024-2029
3.3 Global Afinitor Drug Global Afinitor Drug Revenue by Region: 2018-2029
3.3.1 Global Afinitor Drug Revenue by Region: 2018-2024
3.3.2 Global Afinitor Drug Revenue by Region: 2024-2029
3.4 North America Afinitor Drug Market Facts & Figures by Country
3.4.1 North America Afinitor Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Afinitor Drug Sales by Country (2018-2029)
3.4.3 North America Afinitor Drug Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Afinitor Drug Market Facts & Figures by Country
3.5.1 Europe Afinitor Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Afinitor Drug Sales by Country (2018-2029)
3.5.3 Europe Afinitor Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Afinitor Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Afinitor Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Afinitor Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Afinitor Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Afinitor Drug Market Facts & Figures by Country
3.7.1 Latin America Afinitor Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Afinitor Drug Sales by Country (2018-2029)
3.7.3 Latin America Afinitor Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Afinitor Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Afinitor Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Afinitor Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Afinitor Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Afinitor Drug Sales by Type (2018-2029)
4.1.1 Global Afinitor Drug Sales by Type (2018-2024)
4.1.2 Global Afinitor Drug Sales by Type (2024-2029)
4.1.3 Global Afinitor Drug Sales Market Share by Type (2018-2029)
4.2 Global Afinitor Drug Revenue by Type (2018-2029)
4.2.1 Global Afinitor Drug Revenue by Type (2018-2024)
4.2.2 Global Afinitor Drug Revenue by Type (2024-2029)
4.2.3 Global Afinitor Drug Revenue Market Share by Type (2018-2029)
4.3 Global Afinitor Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Afinitor Drug Sales by Application (2018-2029)
5.1.1 Global Afinitor Drug Sales by Application (2018-2024)
5.1.2 Global Afinitor Drug Sales by Application (2024-2029)
5.1.3 Global Afinitor Drug Sales Market Share by Application (2018-2029)
5.2 Global Afinitor Drug Revenue by Application (2018-2029)
5.2.1 Global Afinitor Drug Revenue by Application (2018-2024)
5.2.2 Global Afinitor Drug Revenue by Application (2024-2029)
5.2.3 Global Afinitor Drug Revenue Market Share by Application (2018-2029)
5.3 Global Afinitor Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Afinitor Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Novartis Afinitor Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Breckenridge
6.2.1 Breckenridge Corporation Information
6.2.2 Breckenridge Description and Business Overview
6.2.3 Breckenridge Afinitor Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Breckenridge Afinitor Drug Product Portfolio
6.2.5 Breckenridge Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Afinitor Drug Industry Chain Analysis
7.2 Afinitor Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Afinitor Drug Production Mode & Process
7.4 Afinitor Drug Sales and Marketing
7.4.1 Afinitor Drug Sales Channels
7.4.2 Afinitor Drug Distributors
7.5 Afinitor Drug Customers
8 Afinitor Drug Market Dynamics
8.1 Afinitor Drug Industry Trends
8.2 Afinitor Drug Market Drivers
8.3 Afinitor Drug Market Challenges
8.4 Afinitor Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Afinitor Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Afinitor Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Afinitor Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Afinitor Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Afinitor Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Afinitor Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Afinitor Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Afinitor Drug Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Afinitor Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Afinitor Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Afinitor Drug, Product Type & Application
Table 12. Global Key Manufacturers of Afinitor Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Afinitor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Afinitor Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Afinitor Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Afinitor Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Afinitor Drug Sales Market Share by Region (2018-2024)
Table 19. Global Afinitor Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Afinitor Drug Sales Market Share by Region (2024-2029)
Table 21. Global Afinitor Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Afinitor Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Afinitor Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Afinitor Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Afinitor Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Afinitor Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Afinitor Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Afinitor Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Afinitor Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Afinitor Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Afinitor Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Afinitor Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Afinitor Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Afinitor Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Afinitor Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Afinitor Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Afinitor Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Afinitor Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Afinitor Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Afinitor Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Afinitor Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Afinitor Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Afinitor Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Afinitor Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Afinitor Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Afinitor Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Afinitor Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Afinitor Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Afinitor Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Afinitor Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Afinitor Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Afinitor Drug Sales Market Share by Type (2018-2024)
Table 53. Global Afinitor Drug Sales Market Share by Type (2024-2029)
Table 54. Global Afinitor Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Afinitor Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Afinitor Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Afinitor Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Afinitor Drug Price (USD/Unit) by Type (2018-2024)
Table 59. Global Afinitor Drug Price (USD/Unit) by Type (2024-2029)
Table 60. Global Afinitor Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Afinitor Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Afinitor Drug Sales Market Share by Application (2018-2024)
Table 63. Global Afinitor Drug Sales Market Share by Application (2024-2029)
Table 64. Global Afinitor Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Afinitor Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Afinitor Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Afinitor Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Afinitor Drug Price (USD/Unit) by Application (2018-2024)
Table 69. Global Afinitor Drug Price (USD/Unit) by Application (2024-2029)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Afinitor Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Novartis Afinitor Drug Product
Table 74. Novartis Recent Developments/Updates
Table 75. Breckenridge Corporation Information
Table 76. Breckenridge Description and Business Overview
Table 77. Breckenridge Afinitor Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Breckenridge Afinitor Drug Product
Table 79. Breckenridge Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Afinitor Drug Distributors List
Table 83. Afinitor Drug Customers List
Table 84. Afinitor Drug Market Trends
Table 85. Afinitor Drug Market Drivers
Table 86. Afinitor Drug Market Challenges
Table 87. Afinitor Drug Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Afinitor Drug
Figure 2. Global Afinitor Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Afinitor Drug Market Share by Type in 2022 & 2029
Figure 4. 2.5mg Product Picture
Figure 5. 5mg Product Picture
Figure 6. 7mg Product Picture
Figure 7. 10mg Product Picture
Figure 8. Global Afinitor Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Afinitor Drug Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Drugs Store
Figure 12. Other
Figure 13. Global Afinitor Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Afinitor Drug Market Size (2018-2029) & (US$ Million)
Figure 15. Global Afinitor Drug Sales (2018-2029) & (K Units)
Figure 16. Global Afinitor Drug Average Price (USD/Unit) & (2018-2029)
Figure 17. Afinitor Drug Report Years Considered
Figure 18. Afinitor Drug Sales Share by Manufacturers in 2022
Figure 19. Global Afinitor Drug Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Afinitor Drug Players: Market Share by Revenue in 2022
Figure 21. Afinitor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Afinitor Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Afinitor Drug Sales Market Share by Country (2018-2029)
Figure 24. North America Afinitor Drug Revenue Market Share by Country (2018-2029)
Figure 25. the United States Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Afinitor Drug Sales Market Share by Country (2018-2029)
Figure 28. Europe Afinitor Drug Revenue Market Share by Country (2018-2029)
Figure 29. Germany Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. UK Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Afinitor Drug Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Afinitor Drug Revenue Market Share by Region (2018-2029)
Figure 36. China Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Afinitor Drug Sales Market Share by Country (2018-2029)
Figure 46. Latin America Afinitor Drug Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Afinitor Drug Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Afinitor Drug Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Afinitor Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Afinitor Drug by Type (2018-2029)
Figure 56. Global Revenue Market Share of Afinitor Drug by Type (2018-2029)
Figure 57. Global Afinitor Drug Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Afinitor Drug by Application (2018-2029)
Figure 59. Global Revenue Market Share of Afinitor Drug by Application (2018-2029)
Figure 60. Global Afinitor Drug Price (USD/Unit) by Application (2018-2029)
Figure 61. Afinitor Drug Value Chain
Figure 62. Afinitor Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries